Detalhe da pesquisa
1.
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
Gastroenterology
; 163(6): 1555-1568, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963369
2.
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata.
J Am Acad Dermatol
; 89(5): 911-919, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019385
3.
A Phase I Study to Evaluate the Safety and Pharmacokinetics of SHR0302 Base Ointment in Healthy Adult Volunteers.
Skin Pharmacol Physiol
; 36(2): 76-86, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580897
4.
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial.
Am J Clin Dermatol
; 22(6): 877-889, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374027